Efficacy and safety of atorvastatin and pravastatin in patients with hypercholesterolemia

Author： Assmann G.   Huwel D.   Schussman K.-M.   Smilde J.G.   Kosling M.   Withagen A.J.A.M.   Wunderlich J.   Stoel I.   van Dormaal J.J.   Neuss J.   Oldenbroek C.   Cuppers M.C.   von Eckardstein A.   Schulte H.   Wagner B.   McLain R.   Black D.M.  

Publisher： Elsevier

ISSN： 0953-6205

Source： European Journal of Internal Medicine, Vol.10, Iss.1, 1999-05, pp. : 33-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial

By McCrindle B.W.   Ose L.   Marais D.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 67-67

Elsevier

Access to resources Recommend Favorite

Rosuvastatin, Pravastatin, and Atorvastatin for the Treatment of Hypercholesterolaemia in HIV-Infected Patients Receiving Protease Inhibitors

By  

Current HIV Research, Vol. 6, Iss. 6, 2008-11 ,pp. : 572-578

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Low-Dose Atorvastatin on Arterial Stiffness and Central Aortic Pressure Augmentation in Patients With Hypertension and Hypercholesterolemia

By Kanaki Aggeliki I.   Sarafidis Pantelis A.   Georgianos Panagiotis I.   Kanavos Konstantinos   Tziolas Ioannis M.   Zebekakis Pantelis E.   Lasaridis Anastasios N.  

American Journal of Hypertension, Vol. 26, Iss. 5, 2013-05 ,pp. : 608-616

Oxford University Press

Access to resources Recommend Favorite

Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects

By Schaefer E.J.   McNamara J.R.   Tayler T.   Daly J.A.   Gleason J.L.   Seman L.J.   Ferrari A.   Rubenstein J.J.  

The American Journal of Cardiology, Vol. 93, Iss. 1, 2004-01 ,pp. : 31-39

Elsevier

Access to resources Recommend Favorite

Safety And Efficacy Of 4 Years Of Deferasirox Treatment For Sickle Cell Disease Patients

By Vlachaki Efthymia  

Hemoglobin, Vol. 37, Iss. 1, 2013-02 ,pp. : 94-100

Informa Healthcare

Access to resources Recommend Favorite